Notable Upgrades: Apple (AAPL), Valeant Pharma (VRX), Yahoo (YHOO), Nexstar (NXST), McDonald’s (MCD), GoPro (GPRO)

In a report published Tuesday, Sterne Agee CRT analysts initiated coverage on Apple Inc. (AAPL) with a ‘Buy’ rating, saying Cupertino has the ability to keep “pushing out the law-of-large-numbers” with its products.

AAPL began trading this morning at $112.79 to currently trade 1.49% lower from the prior days close of $112.44. On an intraday basis it has gotten as low as $110.35 and as high as $113.51.

Apple shares are currently priced at 12.84x this year’s forecasted earnings, compared to the industry’s 12.43x earnings multiple. The company’s current year and next year EPS growth estimates stand at 41.60% and 7.00%, respectively. AAPL has a t-12 price/sales ratio of 2.86. EPS for the same period registers at $8.65.

Apple shares have declined 0.43% in the last 4 weeks and 9.30% in the past three months. Over the past 5 trading sessions the stock has lost 2.40%. Shares of the $632.83 billion market cap company are up 3.16% since the beginning of the year.

Apple has a median Wall Street price target of $150.00 with a high target of $175.00.

Investment analysts at Nomura initiated coverage on shares of Valeant Pharmaceuticals International, Inc. (VRX) in a note issued to investors on Tuesday. The firm set a ‘Buy’ rating and a $290 price target on the stock. Nomura’s price target would suggest a potential upside of about 78% from the stock’s current price of $163.23.

Valeant Pharmaceuticals International Inc., currently valued at $55.95 billion, has a median Wall Street price target of $291.50 with a high target of $304.00. Approximately 8.81 million shares have changed hands intraday, compared to the stock’s average daily volume of 2.90 million.

In the past 52 weeks, shares of the drug maker have traded between a low of $111.41 and a high of $263.81 with the 50-day MA and 200-day MA located at $229.46 and $225.84 levels, respectively. Additionally, shares of VRX trade at a P/E ratio of 67.70 and have a Relative Strength Index (RSI) and MACD indicator of 19.40 and -39.11, respectively.

Valeant Pharmaceuticals currently prints a year-to-date return of around 16%.

Yahoo! Inc. (YHOO) was reiterated a ‘Buy’ by Mizuho analysts on Tuesday. The broker however, cut its price target on the stock to $40 from $43, noting they are lowering their YHOO target price based on a lower Alibaba (BABA) valuation.

Analysts at Jefferies are out with a report this morning upgrading shares of Nexstar Broadcasting Group, Inc. (NXST) with a ‘Buy’ from ‘Hold’ rating.

On valuation measures, Nexstar Broadcasting Group Inc. shares are currently priced at 18.36x this year’s forecasted earnings, which makes them rather expensive compared to the industry’s 9.89x earnings multiple. Ticker has a forward P/E of 10.57 and t-12 price-to-sales ratio of 1.77. EPS for the same period is $2.48.

Over the past year, shares of Irving, Texas-based TV broadcaster have traded between a low of $36.41 and a high of $60.31 and are now at $45.45.

Shares are up 7.99% year-over-year ; down 15.09% year-to-date.

Analysts at Credit Suisse (CS) upgraded their rating on the shares of McDonald’s Corp. (MCD). In a research note published on Tuesday, the firm lifted the name with a ‘Outperform’ from ‘Neutral’ rating and set a 12-month base case estimate of $112 from $100 per share.

On valuation measures, McDonald’s Corp. shares are currently priced at 22.62x this year’s forecasted earnings, compared to the industry’s 18.99x earnings multiple. Ticker has a PEG and forward P/E ratio of 3.10 and 18.89, respectively. Price/Sales for the same period is 3.47 while EPS is $4.30. Currently there are 7 analysts that rate MCD a ‘Buy’, 17 rate it a ‘Hold’. No analyst rates it a ‘Sell’. MCD has a median Wall Street price target of $102 with a high target of $120.

McDonald’s Corp. is up 4.93% year-over-year, compared with a 4.59% loss in the S&P 500.

Shares of GoPro, Inc. (GPRO) are up 0.42, or 1.42%, at $30.09, after Sterne Agee CRT analysts today initiated coverage of the name, giving it a ‘Buy’ rating.

On valuation measures, GPRO shares are currently priced at 26.94x this year’s forecasted earning. Ticker has a forward P/E of 14.65 and t-12 price-to-sales ratio of 2.32. EPS for the same period is $1.12.

In the past 52 weeks, shares of San Mateo, California-based co. have traded between a low of $28.91 and a high of $98.47.

Shares are down 53.07% since the beginning of the year.

Be the first to comment

Leave a Reply

Your email address will not be published.


*